Effect of fetal gender on maternal asthma exacerbations in pregnant asthmatic women

Respiratory Medicine

Volumn 103, Issue 1, 2009, Pages 144-151

  Firoozi, Faranak ^a   Ducharme, Francine M ^c   Lemière, Catherine ^a,b   Beauchesne, Marie France ^a,b   Perreault, Sylvie ^a   Forget, Amélie ^b   Blais, Lucie ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Administrative databases; Asthma; Exacerbation; Fetal gender

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE;

ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FETUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 57949107048     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.07.013     Document Type: Article

References (24)

1. Alexander S., Dodds L., and Armson B.A. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol 92 (1998) 435-440
2. Kwon H.L., Belanger K., and Bracken M.B. Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol 13 (2003) 317-324
3. Olesen C., Steffensen F.H., Nielsen G.L., de Jong-van den Berg L.T.W., Olsen J., and Sorensen H.T. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group. Eur J Clin Pharmacol 55 (1999) 139-144
4. Luskin A.T. An overview of the recommendations of the Working Group on Asthma and Pregnancy. National Asthma Education and Prevention Program. J Allergy Clin Immunol 103 (1999) S350-S353
5. Schatz M. Asthma treatment during pregnancy. What can be safely taken?. Drug Saf 16 (1997) 342-350
6. Schatz M., Harden K., Forsythe A., Chilingar L., Hoffman C., Sperling W., et al. The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol 81 (1988) 509-517
7. Gluck L.C. The change of asthma course during pregnancy. Clin Rev Allergy Immunol 26 (2004) 171-180
8. Beecroft N., Cochrane G.M., and Milburn H.J. Effect of sex of fetus on asthma during pregnancy: blind prospective study. Br Med J 317 (1998) 856-857
9. Dodds L., Armson B.A., and Alexander S. Use of asthma drugs is less among women pregnant with boys rather than girls. [letter; comment]. Br Med J 318 (1999) 1011
10. Kwon H.L., Belanger K., Holford T.R., and Bracken M.B. Effect of fetal sex on airway lability in pregnant women with asthma. Am J Epidemiol 163 (2006) 217-221
11. Derbes V. Reciprocal influences of bronchial asthma and pregnancy. Am J Med 1 (1946) 367-375
12. Baibergenova A., Thabane L., Akhtar-Danesh N., Levine M., and Gafni A. Is fetal gender associated with emergency department visits for asthma during pregnancy?. J Asthma 43 (2006) 293-299
13. Murphy V.E., Gibson P.G., Giles W.B., Zakar T., Smith R., Bisits A.M., et al. Maternal asthma is associated with reduced female fetal growth. Am J Respir Crit Care Med 168 (2003) 1317-1323
14. Clifton V.L., and Murphy V.E. Maternal asthma as a model for examining fetal sex-specific effects on maternal physiology and placental mechanisms that regulate human fetal growth. Placenta 18 (2004) S45-S52
15. Murphy V.E., Gibson P.G., Smith R., and Clifton V.L. Asthma during pregnancy: mechanisms and treatment implications. Eur Respir J 25 (2005) 731-750
16. Clifton V.L. Sexually dimorphic effects of maternal asthma during pregnancy on placental glucocorticoid metabolism and fetal growth. Cell Tissue Res 322 (2005) 63-71
17. Régie de l'Assurance Maladie du Québec. Statistiques annuelles. 10-1-1997. Québec.
18. Tamblyn R., Lavoie G., Petrella L., and Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. J Clin Epidemiol 48 (1995) 999-1009
19. Blais L., Lemière C., Menzies D., and Berbiche D. Validity of asthma diagnoses recorded in the Medical Services database of Quebec. Pharmacoepidemiol Drug Saf 15 (2006) 245-252
20. Martel M.J., Rey E., Beauchesne M.-F., Perreault S., Lefebvre G., Forget A., et al. Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. Br Med J 330 (2005) 230-233
21. Vilain A., Otis S., Forget A., and Blais L. Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women. Pharmacoepidemiol Drug Saf (2008) Epub ahead of print
22. Boulet L.P., Becker A., Berube D., Beveridge R., and Ernst P. Canadian asthma consensus report, 1999. Canadian Asthma Consensus Group. Can Med Assoc J 161 (1999) S1-S61
23. Blais L., Beauchesne M.-F., and Lévesque S. Socioeconomic status and medication prescription patterns in pediatric asthma in Canada. J Adolesc Health 38 (2006) 607 [e9-e16]
24. Firoozi F., Lemière C., Beauchesne M.-F., Forget A., and Blais L. Development and validation of database indexes of asthma severity and control. Thorax (2007) Epub ahead of print